SCHEMBL24693302

SCHEMBL24693302

Cc1cncc2c1c(C[C@@H]1CCNC1)cn2-c1ccc(F)cc1C(=O)N(C(C)C)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.35
SLC6A4 P31645 4/20 0.35
SLC6A3 Q01959 2/20 0.35
KDM1A O60341 1/20 0.32
PTGDR2 Q9Y5Y4 2/20 0.31
TACR1 P25103 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
TP53 P04637 1/20 0.31
THRB P10828 1/20 0.31
IRAK4 Q9NWZ3 5/20 0.31
CHRM3 P20309 1/20 0.31
KCNH2 Q12809 1/20 0.31
SCN2B O60939 1/20 0.30
SCN1B Q07699 1/20 0.30
SCN9A Q15858 1/20 0.30
ADORA2B P29275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24693053 0.94 SLC6A2 (0.34) SLC6A2SLC6A4SLC6A3KDM1APTGDR2
SCHEMBL24693055 0.94 SLC6A2 (0.34) SLC6A2SLC6A4SLC6A3KDM1APTGDR2
SCHEMBL24693333 0.94 SLC6A2 (0.34) SLC6A2SLC6A4SLC6A3KDM1APTGDR2
SCHEMBL24693296 0.92 PTGDR2 (0.34) SLC6A2SLC6A4SLC6A3KDM1APTGDR2
SCHEMBL24693299 0.92 PTGDR2 (0.34) SLC6A2SLC6A4SLC6A3KDM1APTGDR2
SCHEMBL24694371 0.89 BRD3 (0.33) SLC6A2SLC6A4SLC6A3TACR1IRAK4
SCHEMBL24694378 0.89 BRD3 (0.33) SLC6A2SLC6A4SLC6A3TACR1IRAK4
SCHEMBL24693052 0.89 SLC6A4 (0.33) SLC6A2SLC6A4SLC6A3PTGDR2TACR1
SCHEMBL24693078 0.88 MEN1 (0.34) KDM1AMEN1KMT2A
SCHEMBL24693300 0.88 CHRM3 (0.33) KDM1ATP53THRBIRAK4CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250096-A1 SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-08-10 US disclosed
US-20230250096-A1 SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-08-10 US disclosed
WO-2022253167-A1 SUBSTITUTED PHENYL-1H-PYRROLO [2, 3-c] PYRIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250096-A1 SUBSTITUTED PHENYL-1H-PYRROLO[2,3-c] PYRIDINE DERIVATIVES MLLT1, BMI1, MEN1 SLC6A2 4878/4885SLC6A4 4870/4885SLC6A3 4808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.